Prostate News Archive
02-Nov-2011
Prostate cancer screening may do more harm than good
The recent news that a group of highly respected medical experts, the U.S. Preventive Services Task Force, is considering advising against routine prostate cancer screening shouldn't have come as too much of a surprise to anybody. More radionuclide therapy is better for prostate cancer patients, study suggests
For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research. Exelixis Falls on FDA Prostate Cancer Trial Design Setback
Exelixis faces a delay in reaching approval for its prostate cancer drug cabozantinib. Click to view a price quote on EXEL . Click to research the Drugs industry. Researchers target prostate cancer 'pumps'
New research into prostate cancer has found a way to slow the growth of tumour cells. New prostate-cancer screening guidelines may be too conservative for some doctors
A new national recommendation on screening ? or rather, not screening ? for the disease has triggered a stir.
Back to Prostate News Archive
